½ÃÀ庸°í¼­
»óǰÄÚµå
1703418

¼¼°èÀÇ ¾à¹° ¿ëÃâ ½ºÅÙÆ® ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ ¹× ¿¹Ãø - ÄÚÆÃ À¯Çüº°(Æú¸®¸Ó ±â¹Ý ÄÚÆÃ, Æú¸®¸Ó ÇÁ¸® ÄÚÆÃ), ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)

Drug Eluting Stent Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Coating Type (Polymer-based Coatings, Polymer-free Coatings), By Application, By Region & Competition, 2020-2030F

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechSci Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 182 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾à¹° ¿ëÃâ ½ºÅÙÆ®(DES) ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 83¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â±îÁö 8.08%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î °ßÁ¶ÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¼¼°è ÇコÄÉ¾î ºÐ¾ß, ƯÈ÷ ±â¼ú ¹× Çõ½Å ºÐ¾ßÀÇ Å« ¹ßÀüÀº ȯÀÚ Ä¡·á¿Í Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀü ¼Ó¿¡¼­ ¾à¹° ¿ëÃâ ½ºÅÙÆ®´Â ÁßÀçÀû ½ÉÀåÇÐ ºÐ¾ßÀÇ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î µîÀåÇß½À´Ï´Ù. ÀÌ ÀÛÁö¸¸ Áß¿äÇÑ ÀÇ·á±â±â´Â °ü»óµ¿¸ÆÁúȯ(CAD) °ü¸®¿¡ Çõ¸íÀ» °¡Á®¿ÔÀ¸¸ç, Àü ¼¼°è DES ½ÃÀåÀÇ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 83¾ï ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 132¾ï 6,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 8.08%
±Þ¼ºÀå ºÎ¹® Æú¸®¸Ó º£À̽º ÄÚÆÃ
ÃÖ´ë ½ÃÀå ºÏ¹Ì

¾à¹° ¿ëÃâ ½ºÅÙÆ®´Â °ü»óµ¿¸Æ ÁúȯÀ» Ä¡·áÇÏ°í µ¿¸Æ ÀçÇùÂøÀÇ °¡´É¼ºÀ» ÁÙÀ̱â À§ÇØ »ç¿ëµÇ´Â Ư¼ö ÀÇ·á±â±âÀÔ´Ï´Ù. Ç×ÀçÇùÂøÁ¦·Î ÄÚÆÃµÈ ±Ý¼Ó ¸Þ½¬ Æ©ºê·Î ±¸¼ºµÈ DES´Â µ¿¸ÆÀÇ °³Å뼺À» À¯ÁöÇÏ´Â ±¸Á¶Àû ÁöÁöü·Î¼­ÀÇ ±â´É°ú ¾à¹°À» Á¦¾îÀûÀ¸·Î ¹æÃâÇÏ´Â Àü´Þ ½Ã½ºÅÛÀ¸·Î¼­ÀÇ ±â´ÉÀ» °âºñÇϰí ÀÖ½À´Ï´Ù. ÀÌ µÎ °¡Áö ±â´ÉÀ» ÅëÇØ ÇùÂø ¶Ç´Â Æó»öµÈ °ü»óµ¿¸Æ¿¡ DES¸¦ »ðÀÔÇÑ ÈÄ ÀçÇùÂøÀ» ¹æÁöÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¼¼°è Àα¸ÀÇ °í·ÉÈ­

ÁÖ¿ä ½ÃÀå °úÁ¦

±ÔÁ¦»óÀÇ Àå¾Ö¹°

ÁÖ¿ä ½ÃÀå µ¿Çâ

±â¼ú ¹ßÀü

¸ñÂ÷

Á¦1Àå Á¦Ç° °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¾à¹° ¿ëÃâ ½ºÅÙÆ® ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • ÄÚÆÃ À¯Çüº°(Æú¸®¸Ó ±â¹Ý ÄÚÆÃ(ºñ»ýºÐÇØ¼º, »ýºÐÇØ¼º), Æú¸®¸Ó ÇÁ¸® ÄÚÆÃ(¸¶ÀÌÅ©·Î Æ÷·¯½º Ç¥¸é, ¸¶ÀÌÅ©·Î ±¸Á¶ Ç¥¸é, ½½·Ô °ü ¸ð¾ç Ç¥¸é, ³ª³ë Æ÷·¯½º Ç¥¸é))
    • ¿ëµµº°(°ü»óµ¿¸Æ Áúȯ, ¸»Ãʵ¿¸Æ Áúȯ)
    • Áö¿ªº°
    • ±â¾÷º°(2024³â)
  • ½ÃÀå ¸Ê

Á¦6Àå ºÏ¹ÌÀÇ ¾à¹° ¿ëÃâ ½ºÅÙÆ® ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ºÏ¹Ì : ±¹°¡º° ºÐ¼®
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ

Á¦7Àå À¯·´ÀÇ ¾à¹° ¿ëÃâ ½ºÅÙÆ® ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • À¯·´ : ±¹°¡º° ºÐ¼®
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾à¹° ¿ëÃâ ½ºÅÙÆ® ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º° ºÐ¼®
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ

Á¦9Àå ³²¹ÌÀÇ ¾à¹° ¿ëÃâ ½ºÅÙÆ® ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ³²¹Ì : ±¹°¡º° ºÐ¼®
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾à¹° ¿ëÃâ ½ºÅÙÆ® ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦11Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • °úÁ¦

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

  • ÃÖ±Ù µ¿Çâ
  • Á¦Ç° Ãâ½Ã
  • ÀμöÇÕº´(M&A)

Á¦13Àå ¼¼°èÀÇ ¾à¹° ¿ëÃâ ½ºÅÙÆ® ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • Abbott Laboratories Ltd.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic plc
  • Biosensors International Ltd
  • Cook Medical pvt ltd.
  • B. Braun Medical(India) Private Limited
  • Biotronik, Inc.
  • Lepu Medical Technology Inc.

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå ȸ»ç ¼Ò°³ ¹× ¸éÃ¥Á¶Ç×

LSH 25.04.29

Global Drug-eluting stent (DES) market was valued at USD 8.30 billion in 2024 and is projected to experience robust growth, with a compound annual growth rate (CAGR) of 8.08% through 2030. Significant advancements within the global healthcare sector-particularly in technology and innovation-have played a critical role in enhancing patient care and treatment outcomes. Among these advancements, drug-eluting stents have emerged as a transformative solution in interventional cardiology. These small yet vital medical devices are revolutionizing the management of coronary artery disease (CAD), thereby fueling notable expansion in the global DES market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 8.30 Billion
Market Size 2030USD 13.26 Billion
CAGR 2025-20308.08%
Fastest Growing SegmentPolymer-based Coatings
Largest MarketNorth America

Drug-eluting stents are specialized medical devices used to treat coronary artery disease and reduce the likelihood of arterial re-narrowing. Comprising a metallic mesh tube coated with an anti-restenotic drug, DES function both as a structural support to maintain arterial patency and as a delivery system for controlled drug release. This dual function helps prevent restenosis following implantation in narrowed or blocked coronary arteries..

Key Market Drivers

Aging Global Population

The growing elderly population is a major driver of the DES market, as older individuals are more vulnerable to cardiovascular diseases, particularly CAD. With global life expectancy on the rise, demand for minimally invasive cardiac treatments is expected to increase. According to the World Health Organization, the global population aged 60 and above is expected to grow from 1 billion in 2020 to 1.4 billion by 2030 and reach 2.1 billion by 2050. The 80+ age group is also set to triple, rising to 426 million by 2050. This demographic shift has far-reaching implications for healthcare providers and device manufacturers, as cardiovascular treatments such as DES become increasingly essential.

Key Market Challenges

Regulatory Hurdles

One of the primary challenges for the DES market is the constantly evolving regulatory landscape. Regulatory bodies across various regions frequently revise guidelines governing medical devices. As a result, manufacturers must allocate significant resources to ensure ongoing compliance. Securing approvals for new or modified products can be both time-intensive and costly, potentially delaying market entry and impacting profitability.

Key Market Trends

Technological Advancements

Technological innovation is significantly reshaping the global healthcare landscape, with drug-eluting stents at the forefront of progress in interventional cardiology. One of the most notable advancements is the use of biocompatible polymers that optimize drug release kinetics and reduce adverse patient reactions such as inflammation or allergies.

In addition, bioabsorbable stents represent a cutting-edge development. Designed to gradually dissolve within the body, these stents eliminate the long-term complications often associated with permanent metal implants, such as late-stage thrombosis. These innovations are expected to enhance treatment outcomes and further stimulate market growth in the coming years.

Key Market Players

  • Abbott Laboratories ltd.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic plc
  • Biosensors International Ltd
  • Cook Medical pvt ltd.
  • B. Braun Medical (India) Private Limited
  • Biotronik, Inc.
  • Lepu Medical Technology Inc.

Report Scope:

In this report, the Global Drug Eluting Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Drug Eluting Stent Market, By Coating Type:

  • Polymer-based Coatings
  • Polymer-free Coatings

Drug Eluting Stent Market, By Application:

  • Coronary Artery Disease
  • Peripheral Artery Disease

Drug Eluting Stent Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Drug Eluting Stent Market.

Available Customizations:

Global Drug Eluting Stent market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Drug Eluting Stent Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings (Micro porous Surface, Micro structured Surface, Slotted tubular Surface, Nanoporous Surface))
    • 5.2.2. By Application (Coronary Artery Disease, Peripheral Artery Disease)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Drug Eluting Stent Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Coating Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Drug Eluting Stent Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Coating Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Drug Eluting Stent Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Coating Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Drug Eluting Stent Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Coating Type
        • 6.3.3.2.2. By Application

7. Europe Drug Eluting Stent Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Coating Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Drug Eluting Stent Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Coating Type
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Drug Eluting Stent Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Coating Type
        • 7.3.2.2.2. By Application
    • 7.3.3. Italy Drug Eluting Stent Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Coating Type
        • 7.3.3.2.2. By Application
    • 7.3.4. France Drug Eluting Stent Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Coating Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Drug Eluting Stent Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Coating Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Drug Eluting Stent Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Coating Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Drug Eluting Stent Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Coating Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Drug Eluting Stent Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Coating Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Drug Eluting Stent Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Coating Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Drug Eluting Stent Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Coating Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Drug Eluting Stent Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Coating Type
        • 8.3.5.2.2. By Application

9. South America Drug Eluting Stent Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Coating Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Drug Eluting Stent Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Coating Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Drug Eluting Stent Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Coating Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Drug Eluting Stent Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Coating Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Drug Eluting Stent Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Coating Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Drug Eluting Stent Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Coating Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Drug Eluting Stent Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Coating Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Drug Eluting Stent Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Coating Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Drug Eluting Stent Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Abbott Laboratories Ltd.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Boston Scientific Corporation
  • 14.3. Terumo Corporation
  • 14.4. Medtronic plc
  • 14.5. Biosensors International Ltd
  • 14.6. Cook Medical pvt ltd.
  • 14.7. B. Braun Medical (India) Private Limited
  • 14.8. Biotronik, Inc.
  • 14.9. Lepu Medical Technology Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦